Literature DB >> 19755842

The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT function.

Timothy A Chan, Adriana Heguy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19755842      PMCID： PMC6613657          DOI： 10.4161/cc.8.19.9455

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  14 in total

Review 1.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

2.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

3.  Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.

Authors:  M Kovalenko; K Denner; J Sandström; C Persson; S Gross; E Jandt; R Vilella; F Böhmer; A Ostman
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

4.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

Review 5.  Oncogenes come of age.

Authors:  H Varmus; W Pao; K Politi; K Podsypanina; Y-C N Du
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

6.  LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.

Authors:  Claudia Ruivenkamp; Mario Hermsen; Cindy Postma; Anita Klous; Jan Baak; Gerrit Meijer; Peter Demant
Journal:  Oncogene       Date:  2003-05-29       Impact factor: 9.867

7.  Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.

Authors:  Xiaodong Zhang; Ailan Guo; Jianshi Yu; Anthony Possemato; Yueting Chen; Weiping Zheng; Roberto D Polakiewicz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu; Zhenghe John Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

8.  Mutational analysis of the tyrosine phosphatome in colorectal cancers.

Authors:  Zhenghe Wang; Dong Shen; D Williams Parsons; Alberto Bardelli; Jason Sager; Steve Szabo; Janine Ptak; Natalie Silliman; Brock A Peters; Michiel S van der Heijden; Giovanni Parmigiani; Hai Yan; Tian-Li Wang; Greg Riggins; Steven M Powell; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

Review 9.  Protein-tyrosine phosphatases and cancer.

Authors:  Arne Ostman; Carina Hellberg; Frank D Böhmer
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728
View more
  8 in total

1.  Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.

Authors:  Yuhei Kamada; Mamiko Sakata-Yanagimoto; Masashi Sanada; Aiko Sato-Otsubo; Terukazu Enami; Kazumi Suzukawa; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Yasushi Okoshi; Yuichi Hasegawa; Seishi Ogawa; Shigeru Chiba
Journal:  Int J Hematol       Date:  2012-09-13       Impact factor: 2.490

2.  Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining.

Authors:  Junior Tayou
Journal:  Cell Oncol (Dordr)       Date:  2018-04-20       Impact factor: 6.730

Review 3.  Genetic determinants at the interface of cancer and neurodegenerative disease.

Authors:  L G T Morris; S Veeriah; T A Chan
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

4.  Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands.

Authors:  Bladimir J Ovando; Corie A Ellison; Chad M Vezina; James R Olson
Journal:  BMC Genomics       Date:  2010-10-19       Impact factor: 3.969

5.  Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.

Authors:  Vivek Subbiah; Michael J Wagner; Mary F McGuire; Nawid M Sarwari; Eswaran Devarajan; Valerae O Lewis; Shanon Westin; Shumei Kato; Robert E Brown; Pete Anderson
Journal:  Oncotarget       Date:  2015-12-01

6.  Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence.

Authors:  Putty-Reddy Sudhir; Shiu-Ting Lin; Chien Chia-Wen; Shung-Haur Yang; Anna Fen-Yau Li; Rai-Hua Lai; Mei-Jung Wang; Yuan-Tsong Chen; Chian-Feng Chen; Yuh-Shan Jou; Jeou-Yuan Chen
Journal:  Sci Rep       Date:  2015-04-24       Impact factor: 4.379

Review 7.  Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling.

Authors:  Mihwa Kim; Liza D Morales; Ik-Soon Jang; Yong-Yeon Cho; Dae Joon Kim
Journal:  Int J Mol Sci       Date:  2018-09-11       Impact factor: 5.923

8.  Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3.

Authors:  Qiuhua Meng; Jing Tian; Feizhang Qin; Xuejing Huang; Dan Zhu; Bangde Xiang; Min Dong
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.